(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
10 day averaged volume of Blueprint Medicines is 880290
Date | Daily Closing Price | Open | High | Low | Volume |
08 Fri Nov 2024 | 100.83 | 101.58 | 101.97 | 98.95 | 0.71 times |
07 Thu Nov 2024 | 101.39 | 99.33 | 102.47 | 98.59 | 0.793 times |
06 Wed Nov 2024 | 99.63 | 100.00 | 101.48 | 98.41 | 1.097 times |
05 Tue Nov 2024 | 97.55 | 91.00 | 97.67 | 91.00 | 1.067 times |
04 Mon Nov 2024 | 91.88 | 90.70 | 93.00 | 89.50 | 0.659 times |
01 Fri Nov 2024 | 90.70 | 87.53 | 90.85 | 87.28 | 0.704 times |
31 Thu Oct 2024 | 87.51 | 89.23 | 89.61 | 87.31 | 0.948 times |
30 Wed Oct 2024 | 89.24 | 90.92 | 94.98 | 88.80 | 2.174 times |
29 Tue Oct 2024 | 83.40 | 82.67 | 83.48 | 80.68 | 1.356 times |
28 Mon Oct 2024 | 82.77 | 83.33 | 84.64 | 81.67 | 0.72 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 102.3, for a target of 95.2 or 89.31
Share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Target | 80.68 |
Downside Target | 83.91 |
Downside Target | 89.35 |
Downside Target | 94.98 |
Downside Target | 96.50 |
Upside Target | 102.47 |
Upside Target | 106.56 |
Upside Target | 108.40 |
Upside Target | 121.90 |
Intraday share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Intraday Target | 92.73 |
Downside Intraday Target | 84.63 |
Upside Intraday Target | 105.7 |
Upside Intraday Target | 110.57 |
Downside Intraday Target | 97.6 |
Weekly technical analysis of Blueprint Medicines (BPMC)
Date | Weekly Closing Price | Open | High | Low | Volume |
08 Fri Nov 2024 | 100.83 | 90.70 | 102.47 | 89.50 | 0.733 times |
01 Fri Nov 2024 | 90.70 | 83.33 | 94.98 | 80.68 | 1.761 times |
25 Fri Oct 2024 | 82.47 | 85.78 | 87.24 | 81.22 | 1.174 times |
18 Fri Oct 2024 | 86.00 | 87.61 | 91.16 | 85.12 | 1.085 times |
11 Fri Oct 2024 | 88.81 | 88.75 | 90.88 | 85.67 | 0.818 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
Date | Monthly Closing Price | Open | High | Low | Volume |
08 Fri Nov 2024 | 100.83 | 87.53 | 102.47 | 87.28 | 0.305 times |
31 Thu Oct 2024 | 87.51 | 91.63 | 94.98 | 80.68 | 1.055 times |
30 Mon Sep 2024 | 92.50 | 94.80 | 96.50 | 83.91 | 0.853 times |
30 Fri Aug 2024 | 95.54 | 106.51 | 108.40 | 89.35 | 1.157 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Blueprint Medicines in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 91.85 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Blueprint Medicines in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 91.85 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.